The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 32.00
Ask: 33.00
Change: -0.20 (-0.61%)
Spread: 1.00 (3.125%)
Open: 32.70
High: 32.70
Low: 32.50
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Technology Analyst

17 Jan 2012 07:00

RNS Number : 6511V
Merchant Securities Group PLC
17 January 2012
 



 

AIM: MERC

MERCHANT SECURITIES GROUP PLC

("Merchant Securities" or "the Group")

 

Appointment of Technology Analyst

Merchant Securities, the financial services group, is pleased to announce that it has appointed Roger Phillips as Technology Analyst with immediate effect. 

Roger is a highly regarded technology equity analyst. He currently holds the techMARK Analyst of the Year award, which is decided by technology fund managers and techMARK companies, having also previously won this award in 2002. Roger has also been regularly highly ranked in Extel Surveys for both small and large caps.

He joins Merchant Securities from Evolution Securities, where he covered the pan-European technology sector. Prior to this, he held similar roles at Landsbanki and Robert W. Baird. Roger started his career at Deloitte & Touche. 

Patrick Claridge, Chief Executive of Merchant Securities, said:

"We are delighted that Roger is joining our team as we continue to expand our equity research offering. Roger has a well established reputation in the technology sector and I am sure that he will prove a valuable addition to our team."

Enquiries:

 

Merchant Securities Group plc

Tel: +44 (0)20 7375 9022

Patrick Claridge, Chief Executive

Biddicks

Tel: +44 (0)20 3178 6378

Katie Tzouliadis/Sophie McNulty

 

 

Grant Thornton Corporate Finance

Tel: +44 (0)20 7383 5100

Gerry Beaney/Daniela Amihood

 

 

 

Notes to Editors:

 

Merchant Securities Group plc, which was recently acquired by Sanlam UK Limited, offers a broad range of financial services through its Private Client Wealth Management and Investment Banking Divisions.

 

The Investment Banking Division provides financial advisory and execution services to both publicly quoted and private companies. Focusing on small and medium sized companies, it offers a full range of services from corporate finance to equity research, sales and trading.

 

The Private Client Wealth Management Division provides discretionary and advisory wealth management services and financial planning advice to a broad client base, comprising private individuals, small and medium sized businesses, pension funds and charitable trusts. Through both organic growth and recent acquisitions, the Division has developed significantly and it currently holds c. £421 million of assets under advisory management, approximately £80 million of which are under discretionary management.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABKADDOBKDDDD
Date   Source Headline
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.